Thursday September 26Scientific Program 2013-09-26See all Click on the following buttons to choose the program topics that interest you.By categories Gala Dinner: Paris Rive Droite - Escale Borély Boat trip on the «Boréas»along the Seine - Young Investigator Travel Grant & Best Posters awards Gynecological cancers Gastro-intestinal cancers Urological cancers By places Room 1. Room 2. Room 3. By sessions Session 3 Session 4 CTC characterization 3 satellite sessions (selected presentations) CTC in clinical studies Clinical mini symposia CTC characterization 08.30 - 12.35
Session 3
CTC in clinical studies08.50 - 09.10
Molecular characterization of CTC in breast cancerSpeaker : Stefanie S. Jeffrey, Stanford, USA 09.10 - 09.30
CTC in clinical studies: Gastro-Intestinal cancersAttached file :
Speaker : François-Clément Bidard, New-York, USA 09.30 - 09.50
PLS3 expression in circulating blood is a good marker for colon cancer recurrenceSpeaker : Masaki Mori, Osaka, Japan 09.50 - 10.10
Circulating tumor cell biomarkers for unmet needs in prostate cancer drug development and patient managementSpeaker : Howard Scher, New-York, USA 10.10 - 10.40
Coffee break10.40 - 11.00
Lung Cancer CTCs clinical utility and molecular characterisation11.00 - 11.15
Towards the study of bone marrow DTC in breast and ovarian cancerAttached file :
Speaker : Nikolai Tupitsyn, Moscow, Russia 11.15 - 12.15
Selected oral presentations11.15 - 11.30
CTC in clinical studies
Urological cancer (non muscle invasive bladder cancer)Attached file :
Speaker : Paola Gazzaniga 11.30 - 11.45
Going beyond enumeration: Characterization of CTCs and cancer associated cells in Head and Neck Squamous Cell Carcinoma patients11.45 - 12.00
Circulating melanoma cells in stage I-IV patientsAttached file :
Speaker : Anthony Lucci - USA 12.00 - 12.15
Correlation of circulating tumor cells (CTCs) with myeloid-derived suppressive cells (MDSCs) in the peripheral blood of patients with advanced small cell lung carcinoma (SCLC) predicts clinicalAttached file :
Speaker : Ippokratis Messaritakis 12.15 - 12.35
Session 3
Current challenges for clinical implementation of CTC testingSpeaker : Costanza Paoletti, Ann Arbor, USA 12.35 - 14.00
Lunch and Posters Session14.00 - 17.25
Session 4
Molecular characterization of CTC14.00 - 14.25
Challenges in CTC molecular characterizationAttached file :
Speaker : Evi Lianidou, Athens, Greece 14.45 - 15.05
CTC molecular characterization: Are we ready to move forward with clinical testing ?Attached file :
Speaker : Michail Ignatiadis, Brussels, Belgium 15.05 - 15.25
mRNA and microRNA profiling of CTCs from metastatic breast and colorectal cancer patientsAttached file :
15.25 - 16.00
Coffee Break16.00 - 16.20
CTC and DTC in breast cancer - what is and will be the clinical utility?Attached file :
Speaker : Wolfgang Janni, Ulm, Germany 16.20 - 16.40
Detection and characterization of circulating tumor cells from patients with colorectal cancerSpeaker : Sabine Riethdorf, Hamburg, Germany 16.40 - 17.40
CTC characterization
Selected oral presentations16.40 - 16.55
The identification of circulating micro-RNAs (miRNA) to monitor tumour burden in mice bearing small cell lung cancer (SCLC) xenografts established from patient derived circulating tumour cells (CTCs)Speaker : Cassandra Hodgkinson 16.55 - 17.10
Exploring the genomic heterogeneity among circulating tumor cells by next generation sequencingSpeaker : Simon Joosse 17.10 - 17.25
Singe cell genetic analysis helps validating cytopathological identification of CTCs in patients with Clear Cells Renal CarcinomaAttached file :
17.25 - 17.40
Morphology and DNA integrity are defining criteria for diagnostic molecular profiles of single CTCsSpeaker : Bernard Polzer 17.45 - 18.05
Gynecological cancers
Room 1.
Clinical mini symposia
DTCs, CTCs and other prognostic biomarkers for ovarian cancer. What are the top candidates to predict prognosis?Speaker : Sabine Kasimir Bauer, Essen, Germany 17.45 - 18.05
Gastro-intestinal cancers
Room 2.
Circulating tumor cells and colorectal liver surgerySpeaker : Lars Thomas Seeberg 17.45 - 18.05
Urological cancers
Room 3.
Characterization of Invasive CTCs (iCTCs) from Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Speaker : Terence Friedlander 17.55 - 19.10
3 satellite sessions (selected presentations)
Clinical mini symposia18.05 - 18.25
Gynecological cancers
Room 1.
Clinical mini symposia
Matrix metalloproteinase 1 and circulating tumor cells in early breast cancerAttached file :
Speaker : Michal Mego 18.05 - 18.25
Gastro-intestinal cancers
Room 2.
VEFGR expression on CTCs in colon cancer patientsAttached file :
Speaker : Maria Jose Serrano 18.05 - 18.25
Urological cancers
Room 3.
Enumeration and molecular profiling of circulating tumor cells (CTCs) in urothelial cancer (UC) before and during systemic treatmentSpeaker : Emanuela Fina - Milano, Italy 18.25 - 18.45
Gynecological cancers
Room 1.
Circulating tumor cells and triple negative breast cancerAttached file :
Speaker : Carolyn Hall - United States 18.25 - 18.45
Gastro-intestinal cancers
Room 2.
An investigation of Circulating Tumour Cells in Hepatocellular Carcinoma (HCC), .Speaker : Karen Morris 18.25 - 18.45
Urological cancers
Room 3.
Detection and clinical relevance of circulating tumor cells in patients with testicular germ cell tumorsSpeaker : Paulina Nastaly 18.45 - 19.00
Gynecological cancers
Room 1.
CTC metastasis biologyCirculating tumor cells may express HER2 in patients with early Her2 negative breast cancerAttached file :
Speaker : Bernadette Jäger 18.45 - 19.00
Gastro-intestinal cancers
Room 2.
Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancerAttached file :
Speaker : Yoshikazu Uenosono 18.45 - 19.00
Urological cancers
Room 3.
CTC detection in localized prostate cancer: Cellsearch ® and the EPISPOT assaySpeaker : Thibaut Murez 20.00 - 00.00
Gala Dinner: Paris Rive Droite - Escale Borély Boat trip on the «Boréas»along the Seine - Young Investigator Travel Grant & Best Posters awards
|
|
|
